Zobrazeno 1 - 10
of 32
pro vyhledávání: '"H. B. Niznik"'
Publikováno v:
Peripheral Dopamine Pathophysiology ISBN: 9780429278297
This chapter reviews the pharmacology of beta-adrenergic receptor, its coupling to intracellular second messengers and parathyroid hormone (PTH) secretion, and its direct identification by radioligand binding studies. It compares the mechanisms by wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::027e6d435bb328a77dee7201a1e9af8f
https://doi.org/10.1201/9780429278297-10
https://doi.org/10.1201/9780429278297-10
Autor:
F Peretti, V I Adams, Allan I. Levey, J M Wilson, S J Kish, Lee Ang, C Bergeron, John E. Smialek, Kathryn S. Kalasinsky, H. B. Niznik, J Deck, K. Shannak, W R Anderson
Publikováno v:
Annals of Neurology. 40:428-439
Depletion of striatal dopamine (DA) has been hypothesized to explain some of the neurological and psychiatric complications of chronic use of cocaine, including increased risk for neuroleptic-precipitated movement disorders. We measured levels of DA,
Autor:
O. Hornykiewicz, Kathleen Shannak, H. B. Niznik, Mark Guttman, Stephen J. Kish, Lee-Cyn Ang, Julie M. Wilson, Allan I. Levey, Christian Pifl, Alex Rajput
Publikováno v:
Neurology. 47:718-726
To determine the extent that different dopamine (DA) neuronal markers provide similar estimates of striatal (caudate and putamen) DA nerve terminal loss in idiopathic Parkinson's disease (PD), we compared, in postmortem striatum of 12 patients with P
Publikováno v:
Neuroscience. 63:357-362
Dysfunction of dopamine neural systems is hypothesized to underlie neuropsychiatric disorders and psychostimulant drug abuse. At least three dopamine systems have been characterized in the brain-nigrostriatal, mesolimbic, and mesocortical. Abnormalit
Autor:
Roger K. Sunahara, Joel Gelernter, A Pakstis, David L. Pauls, J L Kennedy, R Kurlan, David K. Grandy, Q Y Zhou, H B Niznik, Olivier Civelli
Publikováno v:
American Journal of Psychiatry. 150:449-453
Objective The authors' goal was to establish if a mutation in D1 dopamine receptor locus (DRD1), or one genetically close to it, could cause Gilles de la Tourette's syndrome. Method DRD1 and linked markers (D5S36, D5S61, and D5S62) were studied in a
Publikováno v:
Dopamine in the CNS I ISBN: 9783642627262
Initial classification of dopamine (DA) receptors into D1 and D2 subtypes on the basis of stimulatory and no/inhibitory linkage to adenylyl cyclase (AC), respectively (Spano et al 1978; Kebabian and Calne 1979), endured in substance for approximately
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0a0b816647c74959f3bfcfb3bc5cd70
https://doi.org/10.1007/978-3-642-56051-4_5
https://doi.org/10.1007/978-3-642-56051-4_5
Autor:
B J, Ciliax, N, Nash, C, Heilman, R, Sunahara, A, Hartney, M, Tiberi, D B, Rye, M G, Caron, H B, Niznik, A I, Levey
Publikováno v:
Synapse (New York, N.Y.). 37(2)
Dopamine D(5) receptor localization has been difficult because even the most specific ligands cannot distinguish between molecular subtypes of the D(1)-like receptor subfamily. Antifusion protein rabbit polyclonal antibodies directed against the C-te
Publikováno v:
FEBS letters. 451(2)
The activity of the dopamine transporter is an important mechanism for the maintenance of normal dopaminergic homeostasis by rapidly removing dopamine from the synaptic cleft. In kidney-derived COS-7, COS-1 and HEK-293 but not in other mammalian cell
Publikováno v:
Synapse (New York, N.Y.). 30(1)
Modification of the transport velocity of both the native neuronal and cloned presynaptic dopamine transporter (DAT) has been reported following activation/inhibition of second messenger system pathways. In order to identify the mechanism by which th
Autor:
E L, Barker, M A, Perlman, E M, Adkins, W J, Houlihan, Z B, Pristupa, H B, Niznik, R D, Blakely
Publikováno v:
The Journal of biological chemistry. 273(31)
Human and Drosophila melanogaster serotonin (5-HT) transporters (SERTs) exhibit similar 5-HT transport kinetics and can be distinguished pharmacologically by many, but not all, biogenic amine transporter antagonists. By using human and Drosophila SER